TOP STORIES

• ORGANIZATION Chuikyo Payer Rep Eyes 5%-Plus Discrepancy Threshold or Broader Coverage: 2023 Off-Year Re-Pricing
  September 5, 2022

• ACADEMIA Academic Societies Urge Japan Govt to Approve Shionogi’s COVID-19 Pill
  September 5, 2022

• ORGANIZATION FPMAJ Chief Advocates Drug Price Revision Rule Based on Appropriate Margins for Each Player
  September 2, 2022

• REGULATORY Japan to Supply AstraZeneca’s Evusheld Only for COVID-19 Prevention
  September 2, 2022

• REGULATORY New Expert Panel on Drug Distribution and Pricing Boots Up; 2-Step Proposals Eyed for Off-Year Revision, 2024 Reform
  September 1, 2022

• ORGANIZATION JPMA Proposes New Value-Based Pricing System for Innovative Meds, No Price Cut in Patent Period
  August 31, 2022

• REGULATORY University of Tokyo Selected as Flagship R&D Site to Orchestrate Japan’s Vaccine Efforts: SCARDA Project
  August 31, 2022

• REGULATORY Japan Approves AstraZeneca’s COVID-19 Cocktail Therapy Evusheld
  August 30, 2022

• REGULATORY AstraZeneca’s COVID Cocktail in Line for Approval, Comirnaty Booster for Ages 5-11
  August 30, 2022

• COMMENTARY Tussle in Japan Diabetes Market Heating Up; BI and Sumitomo Nip and Tuck for No. 1 Slot
  August 29, 2022

• REGULATORY Lilly’s Tirzepatide in Line for Approval as Early as September as Japan’s 1st GIP/GLP-1 Agent
  August 26, 2022

• REGULATORY Japan Approves Label Expansions for Lynparza, Ultomiris, Keytruda, Tagrisso, and More
  August 25, 2022

• BUSINESS BMS Wants to Jolt Cancer Care Landscape with Broader I/O Combo Options, Pursuing LAG-3 Inhibitor in Japan Too
  August 24, 2022

• REGULATORY MHLW to Boost Orphan Program to Fuel New Drug Development: FY2023 Budget Request
  August 23, 2022

• REGULATORY After Repeated Scandals, PMDA Sets Up New Division to Provide GMP Inspection Know-How to Prefectures
  August 22, 2022

• REGULATORY Operational Issues of Emergency Approval Scheme Will Be Addressed If Needed: Pharma Bureau Chief
  August 19, 2022

• BUSINESS Lagevrio Joins NHI Price List, Normal Distribution to Start Once Ready
  August 19, 2022

• BUSINESS Incyte Japan Urges Reward for Innovation in Rare Diseases as Pemazyre Filed for Ultra Orphan Cancer
  August 18, 2022

• ORGANIZATION JaDHA Hopes to Issue First Policy Proposal to Solve Digital Health Challenges by Year-End: Chairman
  August 17, 2022

• REGULATORY AZ’s Asthma Drug Tezepelumab Up for MHLW Panel Review on August 29
  August 17, 2022

ページ

• « 先頭
• ‹ Prev
• …
• 66
• 67
• 68
• 69
• 70
• 71
• 72
• 73
• 74
• …
• Next ›
• 最終 »